706
Toxicologie nucléaire environnementale et humaine
Références bibliographiques
Ansoborlo E, Amekraz B, Moulin C, Moulin
V, Taran F, Bailly T, Burgada R, HengéNapoli M. H, Jeanson A, Den Auwer C,
Bonin L, Moisy P (2007). Review of actinide decorporation with chelating agents.
C R Chimie, 10 : 1010-1019.
ASN (Autorité de sûreté nucléaire) (2008).
Guide national d’intervention médicale en
cas d’événement nucléaire ou radiologique.
V3.6.
Burgada R, Bailly T, Prangé T, Lecouvey M
(2007). Synthetic strategy of new powerful
tris-biphosphonic ligands for chelation of
uranyl, iron and cobalt cations. Tetrahedron Letters, 48 : 2315-2319.
Chen H, Kaminski M, Liu X, Mertz CJ, Xie
Y, Torno MD, Rosengart (2007). A novel
human detoxification system based on
nanoscale bioengineering and magnetic
separation techniques. Medical hypotheses,
68 : 1071-1079.
Durbin PW (2006). Actinides in animals and
man. In: Morss LR, Edelstein NM, Fuger
J, Katz J. The chemistry of the actinide and
transactinide elements, 3rd edition, Springer, 3339-3425.
FDA (Food and drug administration) (2006).
Guidance for industry: Internal Radioactive contamination - Development of
decorporation agents. US department of
health and human services.
Fouillit M, Grillon G, Fritsch P, Rateau G,
Pavé D, Delforge J, Le Gall B (2004).
Comparative tissue uptake and cellular
deposition of three different plutonium
chemical forms in rat. Int J Radiat Biol,
80 : 683-9689.
Gervelas C, Serandour AL, Geiger S, Grillon
G, Fritsch P, Taulelle C, Le Gall B, Deverre
JR, Fattal E, Tsapis N (2007). Direct lung
delivery of a dry powder formulation of
DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. J Control Release
118 : 78-86.
Gorden AEV, Xu J, Raymond KN, Durbin
P (2003). Rational design of sequestering
agents for plutonium and other actinides.
Chern Rev, 103 : 4207-4280.
Grappin L, Bérard P, Beau P, Carbone L, Castagnet X, Courtay C, Le Goff JP, Ménétrier
F, Néron MO, Piechowski J (2006). Exposition aux actinides : bilan des injections de
Ca-DTPA dans les centres CEA-COGEMA
- Rapport CEA-R-6097, ISSN 0429-3460.
Guilmette RA, Hakimi R, Durbin PW, Xu
J, Raymond KN (2003). Competitive binding of Pu and Am with bone mineral land
novel chelating agents. Radiat Prot Dosim,
105 : 527-534.
Hengé-Napoli MH, Stradling GN, Taylor DM
(2000). Decorporation of radionuclides
from the human body. Radiat Prot Dosim,
87 : 11-57.
Kaminski MD, Rosengart AJ (2005). Detoxification of blood using injectable magnetic
nanospheres: a conceptual technology description. J Magn Mater, 293 : 398-403.
Le Gall B, Taran F, Renault D, Wilk JC, Ansoborlo E (2006). Comparison of Prussian blue
and apple-pectin efficacy on l37Cs decorporation in rats. Biochimie, 88 : 1837-1841.
Leydier A, Lecerclé D, Pellet-Rostaing S,
Fabre-Reguillon A, Taran F, Lemaire M
(2008). Sequesting agent for uranyl chelation: a new family of CAMS ligands.
Tetrahedron, 64 : 6662-6669.
Leydier A, Lecerclé D, Pellet-Rostaing S,
Fabre-Reguillon A, Taran F, Lemaire M
(2008). Sequesting agent for uranyl chelation: new calixarene ligands. Tetrahedron,
64 : 11319-11324.
Ménétrier F, Grappin L, Raynaud P, Courtay
C, Wood R, Joussineau S, List, Stradling
GN, Taylor DM, Bérard P, Morcillo MA,
Rencova J (2005). Treatment of accidental intakes of plutonium and americium:
guidance notes - Applied Radiation and
Isotopes, 62 : 829-846.
Meunier S, Siaugue J-M, Sawicki M, Calbour F, Dézard S, Taran F, Mioskowski
C (2003). Modular liquid-phase parallel
synthesis of a highly diverse ligand library.
J Comb Chern, 5 : 201-204.
Phan G, Ramounet-Le Gall B, Manceau, 5
Benech H, Fritsch P, Fattal E, Deverre JR |
(2004). Targeting of diethylene triamine
pentaacetic acid encapsulated in liposomes
p h o to c o p ie n o n
a u to ris é e e s t u n
d é lit
Toxicologie nucléaire environnementale et humaine
Références bibliographiques
Ansoborlo E, Amekraz B, Moulin C, Moulin
V, Taran F, Bailly T, Burgada R, HengéNapoli M. H, Jeanson A, Den Auwer C,
Bonin L, Moisy P (2007). Review of actinide decorporation with chelating agents.
C R Chimie, 10 : 1010-1019.
ASN (Autorité de sûreté nucléaire) (2008).
Guide national d’intervention médicale en
cas d’événement nucléaire ou radiologique.
V3.6.
Burgada R, Bailly T, Prangé T, Lecouvey M
(2007). Synthetic strategy of new powerful
tris-biphosphonic ligands for chelation of
uranyl, iron and cobalt cations. Tetrahedron Letters, 48 : 2315-2319.
Chen H, Kaminski M, Liu X, Mertz CJ, Xie
Y, Torno MD, Rosengart (2007). A novel
human detoxification system based on
nanoscale bioengineering and magnetic
separation techniques. Medical hypotheses,
68 : 1071-1079.
Durbin PW (2006). Actinides in animals and
man. In: Morss LR, Edelstein NM, Fuger
J, Katz J. The chemistry of the actinide and
transactinide elements, 3rd edition, Springer, 3339-3425.
FDA (Food and drug administration) (2006).
Guidance for industry: Internal Radioactive contamination - Development of
decorporation agents. US department of
health and human services.
Fouillit M, Grillon G, Fritsch P, Rateau G,
Pavé D, Delforge J, Le Gall B (2004).
Comparative tissue uptake and cellular
deposition of three different plutonium
chemical forms in rat. Int J Radiat Biol,
80 : 683-9689.
Gervelas C, Serandour AL, Geiger S, Grillon
G, Fritsch P, Taulelle C, Le Gall B, Deverre
JR, Fattal E, Tsapis N (2007). Direct lung
delivery of a dry powder formulation of
DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. J Control Release
118 : 78-86.
Gorden AEV, Xu J, Raymond KN, Durbin
P (2003). Rational design of sequestering
agents for plutonium and other actinides.
Chern Rev, 103 : 4207-4280.
Grappin L, Bérard P, Beau P, Carbone L, Castagnet X, Courtay C, Le Goff JP, Ménétrier
F, Néron MO, Piechowski J (2006). Exposition aux actinides : bilan des injections de
Ca-DTPA dans les centres CEA-COGEMA
- Rapport CEA-R-6097, ISSN 0429-3460.
Guilmette RA, Hakimi R, Durbin PW, Xu
J, Raymond KN (2003). Competitive binding of Pu and Am with bone mineral land
novel chelating agents. Radiat Prot Dosim,
105 : 527-534.
Hengé-Napoli MH, Stradling GN, Taylor DM
(2000). Decorporation of radionuclides
from the human body. Radiat Prot Dosim,
87 : 11-57.
Kaminski MD, Rosengart AJ (2005). Detoxification of blood using injectable magnetic
nanospheres: a conceptual technology description. J Magn Mater, 293 : 398-403.
Le Gall B, Taran F, Renault D, Wilk JC, Ansoborlo E (2006). Comparison of Prussian blue
and apple-pectin efficacy on l37Cs decorporation in rats. Biochimie, 88 : 1837-1841.
Leydier A, Lecerclé D, Pellet-Rostaing S,
Fabre-Reguillon A, Taran F, Lemaire M
(2008). Sequesting agent for uranyl chelation: a new family of CAMS ligands.
Tetrahedron, 64 : 6662-6669.
Leydier A, Lecerclé D, Pellet-Rostaing S,
Fabre-Reguillon A, Taran F, Lemaire M
(2008). Sequesting agent for uranyl chelation: new calixarene ligands. Tetrahedron,
64 : 11319-11324.
Ménétrier F, Grappin L, Raynaud P, Courtay
C, Wood R, Joussineau S, List, Stradling
GN, Taylor DM, Bérard P, Morcillo MA,
Rencova J (2005). Treatment of accidental intakes of plutonium and americium:
guidance notes - Applied Radiation and
Isotopes, 62 : 829-846.
Meunier S, Siaugue J-M, Sawicki M, Calbour F, Dézard S, Taran F, Mioskowski
C (2003). Modular liquid-phase parallel
synthesis of a highly diverse ligand library.
J Comb Chern, 5 : 201-204.
Phan G, Ramounet-Le Gall B, Manceau, 5
Benech H, Fritsch P, Fattal E, Deverre JR |
(2004). Targeting of diethylene triamine
pentaacetic acid encapsulated in liposomes
p h o to c o p ie n o n
a u to ris é e e s t u n
d é lit